Literature DB >> 27895018

Occurrence of Diverse AbGRI1-Type Genomic Islands in Acinetobacter baumannii Global Clone 2 Isolates from South Korea.

Dae Hun Kim1, Sook-In Jung2, Ki Tae Kwon3, Kwan Soo Ko4.   

Abstract

In this study, we analyzed the frequency of the AbGRI1-type genomic island (GI) and its association with genotypes. We obtained 130 Acinetobacter baumannii isolates causing bloodstream infections from patients in South Korea. Antimicrobial susceptibility testing and multilocus sequence typing were performed. The presence of AbGRI1-type GIs and their structures were determined by sequential PCR and sequencing. Ninety-eight isolates (75.3%) representing 14 sequence types (STs) belonged to clonal complex 208 (CC208), corresponding to global clone 2 (GC2). AbGRI1-type GIs interrupted the comM gene in 107 isolates (82.4%). Four types of GIs were identified: Tn6022 (50 isolates; 46.7%), AbaR4 (23 isolates; 21.5%), Tn6166 (10 isolates; 9.3%), and Tn6166/Tn2006 (24 isolates; 22.4%). In the 50 isolates with Tn6022, Tn2006 or Tn2008B, both containing ISAba1-blaOXA-23, was present in sites other than GIs in 3 or 28 isolates, respectively. In the 10 isolates with Tn6166, Tn2008B was identified in one isolate. AbGRI1-type GIs were identified nearly exclusively in CC208 isolates, with the exception of nine non-CC208 isolates (AbaR4 in eight ST229 isolates and Tn6022 in one ST1244 isolate). Within CC208 isolates, there was evidence of frequent recombination events, in both housekeeping genes and AbGRI1-type GIs, contributing to genotype diversification and the emergence of carbapenem resistance.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  AbaR4; Tn6022; Tn6166; blaOXA-23; carbapenem resistance; resistance island

Mesh:

Substances:

Year:  2017        PMID: 27895018      PMCID: PMC5278748          DOI: 10.1128/AAC.01972-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Variations of AbaR4-type resistance islands in Acinetobacter baumannii isolates from South Korea.

Authors:  Dae Hun Kim; Young Kyoung Park; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2012-06-05       Impact factor: 5.191

Review 2.  Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene.

Authors:  Steven J Nigro; Ruth M Hall
Journal:  J Antimicrob Chemother       Date:  2016-01-10       Impact factor: 5.790

Review 3.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

4.  AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital.

Authors:  Mohammad Hamidian; Ruth M Hall
Journal:  J Antimicrob Chemother       Date:  2011-08-26       Impact factor: 5.790

5.  Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii.

Authors:  Sergio G Bartual; Harald Seifert; Corinna Hippler; M Angeles Domínguez Luzon; Hilmar Wisplinghoff; Francisco Rodríguez-Valera
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

7.  High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

Authors:  Doo Ryeon Chung; Jae-Hoon Song; So Hyun Kim; Visanu Thamlikitkul; Shao-Guang Huang; Hui Wang; Thomas Man-Kit So; Rohani M D Yasin; Po-Ren Hsueh; Celia C Carlos; Li Yang Hsu; Latre Buntaran; M K Lalitha; Min Ja Kim; Jun Yong Choi; Sang Il Kim; Kwan Soo Ko; Cheol-In Kang; Kyong Ran Peck
Journal:  Am J Respir Crit Care Med       Date:  2011-09-15       Impact factor: 21.405

8.  Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.

Authors:  Zhi Ruan; Yan Chen; Yan Jiang; Hua Zhou; Zhihui Zhou; Ying Fu; Haiping Wang; Yanfei Wang; Yunsong Yu
Journal:  Int J Antimicrob Agents       Date:  2013-08-09       Impact factor: 5.283

9.  Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands.

Authors:  Dae Hun Kim; Ji-Young Choi; Hae Won Kim; So Hyun Kim; Doo Ryeon Chung; Kyong Ran Peck; Visanu Thamlikitkul; Thomas Man-Kit So; Rohani M D Yasin; Po-Ren Hsueh; Celia C Carlos; Li Yang Hsu; Latre Buntaran; M K Lalitha; Jae-Hoon Song; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

10.  PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods.

Authors:  Alexandre P Francisco; Cátia Vaz; Pedro T Monteiro; José Melo-Cristino; Mário Ramirez; Joäo A Carriço
Journal:  BMC Bioinformatics       Date:  2012-05-08       Impact factor: 3.169

View more
  10 in total

1.  Acinetobacter baumannii: Epidemiological and Beta-Lactamase Data From Two Tertiary Academic Hospitals in Tshwane, South Africa.

Authors:  Michelle Lowe; Marthie M Ehlers; Farzana Ismail; Gisele Peirano; Piet J Becker; Johann D D Pitout; Marleen M Kock
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

2.  Genomic Analysis of Consecutive Acinetobacter baumannii Strains From a Single Patient.

Authors:  Sun Ju Kim; Yae-Jean Kim; Kwan Soo Ko
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

3.  Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii.

Authors:  Chorong Hahm; Hae-Sun Chung; Miae Lee
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

4.  Whole genome sequence of pan drug-resistant clinical isolate of Acinetobacter baumannii ST1890.

Authors:  Thanwa Wongsuk; Siriphan Boonsilp; Anchalee Homkaew; Konrawee Thananon; Worrapoj Oonanant
Journal:  PLoS One       Date:  2022-03-09       Impact factor: 3.240

5.  Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Isolates Among Intensive Care Unit Patients and Environment.

Authors:  Hangbin Hu; Yifeng Lou; Haiting Feng; Jingjing Tao; Weixiao Shi; Shuangling Ni; Qunying Pan; Tianxiang Ge; Ping Shen; Zifeng Zhong; Yonghong Xiao; Tingting Qu
Journal:  Infect Drug Resist       Date:  2022-04-13       Impact factor: 4.177

6.  The Changes in Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit for 17 Years.

Authors:  Dongsub Kim; Haejeong Lee; Joon-Sik Choi; Christina M Croney; Ki-Sup Park; Hyo Jung Park; Joongbum Cho; Sohee Son; Jin Yeong Kim; Soo-Han Choi; Hee Jae Huh; Kwan Soo Ko; Nam Yong Lee; Yae-Jean Kim
Journal:  J Korean Med Sci       Date:  2022-06-20       Impact factor: 5.354

7.  Genetic Configuration of Genomic Resistance Islands in Acinetobacter baumannii Clinical Isolates From Egypt.

Authors:  Samira M Hamed; Amira F A Hussein; Mohamed H Al-Agamy; Hesham H Radwan; Mai M Zafer
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

8.  Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications.

Authors:  Min Hyung Kim; Haeyoung Jeong; Young Mi Sim; Soohyun Lee; Dongeun Yong; Choong-Min Ryu; Jun Yong Choi
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

9.  Blp1 protein shows virulence-associated features and elicits protective immunity to Acinetobacter baumannii infection.

Authors:  Jūratė Skerniškytė; Emilija Karazijaitė; Julien Deschamps; Renatas Krasauskas; Julija Armalytė; Romain Briandet; Edita Sužiedėlienė
Journal:  BMC Microbiol       Date:  2019-11-21       Impact factor: 3.605

10.  Acquisition of plasmids conferring carbapenem and aminoglycoside resistance and loss of surface-exposed macromolecule structures as strategies for the adaptation of Acinetobacter baumannii CC104O/CC15P strains to the clinical setting.

Authors:  María M Cameranesi; Julian Paganini; Adriana S Limansky; Jorgelina Moran-Barrio; Suzana P Salcedo; Alejandro M Viale; Guillermo D Repizo
Journal:  Microb Genom       Date:  2020-03-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.